Advertisement
LAZR vs VRTX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAZR is a Hold and VRTX is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LAZR’s FA Score shows that 1 FA rating(s) are green whileVRTX’s FA Score has 2 green FA rating(s).
- LAZR’s FA Score: 1 green, 4 red.
- VRTX’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LAZR’s TA Score shows that 5 TA indicator(s) are bullish while VRTX’s TA Score has 6 bullish TA indicator(s).
- LAZR’s TA Score: 5 bullish, 3 bearish.
- VRTX’s TA Score: 6 bullish, 3 bearish.
Price Growth
LAZR (@Auto Parts: OEM) experienced а +13.19% price change this week, while VRTX (@Biotechnology) price change was -3.39% for the same time period.
The average weekly price growth across all stocks in the @Auto Parts: OEM industry was +0.21%. For the same industry, the average monthly price growth was +7.81%, and the average quarterly price growth was +11.84%.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.
Reported Earning Dates
LAZR is expected to report earnings on May 20, 2025.
VRTX is expected to report earnings on Oct 29, 2025.
Industries' Descriptions
@Auto Parts: OEM (+0.21% weekly)OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.
@Biotechnology (+2.49% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| LAZR | VRTX | LAZR / VRTX | |
| Capitalization | 831M | 118B | 1% |
| EBITDA | -524.91M | -74.9M | 701% |
| Gain YTD | -39.405 | 15.041 | -262% |
| P/E Ratio | N/A | 32.76 | - |
| Revenue | 69.8M | 11.1B | 1% |
| Total Cash | 290M | 6.2B | 5% |
| Total Debt | 661M | 1.65B | 40% |
LAZR | VRTX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 12 | 7 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 100 Overvalued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 33 | |
SMR RATING 1..100 | 100 | 91 | |
PRICE GROWTH RATING 1..100 | 65 | 55 | |
P/E GROWTH RATING 1..100 | 2 | 30 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
VRTX's Valuation (77) in the Biotechnology industry is in the same range as LAZR (100) in the null industry. This means that VRTX’s stock grew similarly to LAZR’s over the last 12 months.
VRTX's Profit vs Risk Rating (33) in the Biotechnology industry is significantly better than the same rating for LAZR (100) in the null industry. This means that VRTX’s stock grew significantly faster than LAZR’s over the last 12 months.
VRTX's SMR Rating (91) in the Biotechnology industry is in the same range as LAZR (100) in the null industry. This means that VRTX’s stock grew similarly to LAZR’s over the last 12 months.
VRTX's Price Growth Rating (55) in the Biotechnology industry is in the same range as LAZR (65) in the null industry. This means that VRTX’s stock grew similarly to LAZR’s over the last 12 months.
LAZR's P/E Growth Rating (2) in the null industry is in the same range as VRTX (30) in the Biotechnology industry. This means that LAZR’s stock grew similarly to VRTX’s over the last 12 months.
| LAZR | VRTX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 74% | 1 day ago 53% |
| Stochastic ODDS (%) | 2 days ago 79% | 1 day ago 65% |
| Momentum ODDS (%) | 2 days ago 86% | 1 day ago 65% |
| MACD ODDS (%) | 2 days ago 82% | N/A |
| TrendWeek ODDS (%) | 2 days ago 79% | 1 day ago 44% |
| TrendMonth ODDS (%) | 2 days ago 76% | 1 day ago 63% |
| Advances ODDS (%) | 2 days ago 83% | 9 days ago 59% |
| Declines ODDS (%) | 8 days ago 87% | 1 day ago 43% |
| BollingerBands ODDS (%) | 2 days ago 90% | 1 day ago 45% |
| Aroon ODDS (%) | 2 days ago 85% | 1 day ago 55% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IJK | 92.86 | 1.16 | +1.26% |
| iShares S&P Mid-Cap 400 Growth ETF | |||
| AOK | 38.82 | 0.18 | +0.47% |
| iShares Core 30/70 Cnsrv Allc ETF | |||
| PSCJ | 28.56 | 0.08 | +0.27% |
| Pacer Swan SOS Conservative (July) ETF | |||
| CPSY | 24.24 | 0.03 | +0.12% |
| Calamos S&P 500 Str Alt Prt ETF-Jan | |||
| FDEV | 32.02 | -0.04 | -0.14% |
| Fidelity International Multifactor ETF | |||
LAZR and
Correlation & Price change
A.I.dvisor indicates that over the last year, LAZR has been loosely correlated with AEVA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if LAZR jumps, then AEVA could also see price increases.
| Ticker / NAME | Correlation To LAZR | 1D Price Change % | ||
|---|---|---|---|---|
| LAZR | 100% | +12.03% | ||
| AEVA - LAZR | 57% Loosely correlated | +11.32% | ||
| LKQ - LAZR | 34% Loosely correlated | +0.27% | ||
| QS - LAZR | 34% Loosely correlated | +19.82% | ||
| XPEL - LAZR | 31% Poorly correlated | N/A | ||
| GGR - LAZR | 31% Poorly correlated | +4.83% | ||
More | ||||